These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8562314)

  • 1. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils.
    Kaneko T; Alvarez R; Ueki IF; Nadel JA
    Cell Signal; 1995 Jul; 7(5):527-34. PubMed ID: 8562314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
    Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
    Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation.
    Teixeira MM; Rossi AG; Giembycz MA; Hellewell PG
    Br J Pharmacol; 1996 Aug; 118(8):2099-106. PubMed ID: 8864548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression.
    Momose T; Okubo Y; Horie S; Suzuki J; Isobe M; Sekiguchi M
    Int Arch Allergy Immunol; 1998 Oct; 117(2):138-45. PubMed ID: 9784658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro.
    Alves AC; Pires AL; Lagente V; Cordeiro RS; Martins MA; e Silva PM
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():201-4. PubMed ID: 9698934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
    Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
    Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
    Ezeamuzie CI
    Eur J Pharmacol; 2001 Apr; 417(1-2):11-8. PubMed ID: 11301054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis.
    Hidi R; Timmermans S; Liu E; Schudt C; Dent G; Holgate ST; Djukanović R
    Eur Respir J; 2000 Feb; 15(2):342-9. PubMed ID: 10706503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF.
    Hallsworth MP; Giembycz MA; Barnes PJ; Lee TH
    Br J Pharmacol; 1996 Jan; 117(1):79-86. PubMed ID: 8825346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
    Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H(2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation.
    Ezeamuzie CI; Philips E
    Br J Pharmacol; 2000 Oct; 131(3):482-8. PubMed ID: 11015298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals.
    Warringa RA; Mengelers HJ; Kuijper PH; Raaijmakers JA; Bruijnzeel PL; Koenderman L
    Blood; 1992 Apr; 79(7):1836-41. PubMed ID: 1558975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.
    Bruijnzeel PL; Kuijper PH; Rihs S; Betz S; Warringa RA; Koenderman L
    J Invest Dermatol; 1993 Feb; 100(2):137-42. PubMed ID: 8429236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibutyryl cyclic AMP induces formyl peptide receptor expression and chemotactic responses in a human eosinophilic cell line, EoL-1.
    Uenoyama Y; Ohshima Y; Morita M; Akutagawa H; Nambu M; Kim KM; Mayumi M; Mikawa H
    Exp Hematol; 1991 Sep; 19(8):823-8. PubMed ID: 1651253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
    Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis.
    Yoshikawa M; Matsumoto K; Iida M; Akasawa A; Moriyama H; Saito H
    Int Arch Allergy Immunol; 2002; 128 Suppl 1():3-11. PubMed ID: 12065903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.